{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:41:29Z","timestamp":1766983289767,"version":"build-2065373602"},"reference-count":95,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Dental and Craniofacial Research (NIDCR)","award":["R01 DE-014344","AI-0819529"],"award-info":[{"award-number":["R01 DE-014344","AI-0819529"]}]},{"name":"National Institute of Allergy and Infectious Diseases (NIAID)","award":["R01 DE-014344","AI-0819529"],"award-info":[{"award-number":["R01 DE-014344","AI-0819529"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The C57BL\/6.NOD-Aec1Aec2 mouse has been extensively studied to define the underlying cellular and molecular basis for the onset and development of Sj\u00f6gren\u2019s syndrome (SS), a human systemic autoimmune disease characterized clinically as the loss of normal lacrimal and salivary gland functions leading respectively to dry eye and dry mouth pathologies. While an overwhelming majority of SS studies in both humans and rodent models have long focused primarily on pathophysiological events and the potential role of T lymphocytes in these events, recent studies in our murine models have indicated that marginal zone B (MZB) lymphocytes are critical for both development and onset of SS disease. Although migration and function of MZB cells are difficult to study in vivo and in vitro, we have carried out ex vivo investigations that use temporal global RNA transcriptomic analyses to track early cellular and molecular events in these exocrine glands of C57BL\/6.NOD-Aec1Aec2 mice. In the present report, genome-wide transcriptome analyses of lacrimal glands indicate that genes and gene-sets temporally upregulated during early onset of disease define the Notch2\/NF-k\u03b214 and Type1 interferon signal transduction pathways, as well as identify chemokines, especially Cxcl13, and Rho-GTPases, including DOCK molecules, in the cellular migration of immune cells to the lacrimal glands. We discuss how the current results compare with our recently published salivary gland data obtained from similar studies carried out in our C57BL\/6.NOD-Aec1Aec2 mice, pointing out both similarities and differences in the etiopathogeneses underlying the autoimmune response within the two glands. Overall, this study uses the power of transcriptomic analyses to identify temporal molecular bioprocesses activated during the preclinical covert pathogenic stage(s) of SS disease and how these findings may impact future intervention therapies as the disease within the two exocrine glands may not be identical.<\/jats:p>","DOI":"10.3390\/ijms23116106","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T23:43:03Z","timestamp":1653867783000},"page":"6106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A MZB Cell Activation Profile Present in the Lacrimal Glands of Sj\u00f6gren\u2019s Syndrome-Susceptible C57BL\/6.NOD-Aec1Aec2 Mice Defined by Global RNA Transcriptomic Analyses"],"prefix":"10.3390","volume":"23","author":[{"given":"Ammon B.","family":"Peck","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, P.O. Box 100125, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-4075","authenticated-orcid":false,"given":"Cuong Q.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, P.O. Box 100125, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-796X","authenticated-orcid":false,"suffix":"Jr.","given":"Julian L.","family":"Ambrus","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, P.O. Box 100125, Gainesville, FL 32610, USA"},{"name":"Division of Allergy, Immunology and Rheumatology, SUNY Buffalo School of Medicine, 875 Ellicott Street, Buffalo, NY 14203, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","article-title":"Sjogren\u2019s syndrome: An update on disease pathogenesis, clinical manifestations and treatment","volume":"203","author":"Vivino","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","article-title":"Autoimmunity and primary immunodeficiency: Two sides of the same coin?","volume":"14","author":"Schmidt","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fimmu.2019.02305","article-title":"The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coi.2019.08.006","article-title":"Shared and unique immune alterations in pre-clinical autoimmunity","volume":"61","author":"Bourn","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2019.07.001","article-title":"Metabolic regulation of pathogenic autoimmunity: Therapeutic targeting","volume":"61","author":"Teng","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_6","first-page":"S185","article-title":"Type I interferon signature in Sjogren\u2019s syndrome: Pathophysiological and clinical implications","volume":"37","author":"Marketos","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sjogren\u2019s syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Theander","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Sjogren\u2019s histopathology workshop group from, E. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2018.01512","article-title":"The Therapeutic and Pathogenic Role of Autophagy in Autoimmune Diseases","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/bor.0000174210.78449.6b","article-title":"Familial autoinflammatory diseases: Genetics, pathogenesis and treatment","volume":"17","author":"Stojanov","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_11","first-page":"3","article-title":"Crossroads of B cell activation in autoimmunity: Rationale of targeting B cells","volume":"77","author":"Dorner","year":"2006","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B Cells and Plasma Cells in Autoimmune Diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.semarthrit.2018.10.007","article-title":"Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases","volume":"48","author":"Sakkas","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sjogren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sjogren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2741\/2187","article-title":"Sjogren\u2019s syndrome (SjS)-like disease of mice: The importance of B lymphocytes and autoantibodies","volume":"12","author":"Nguyen","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12016-011-8288-5","article-title":"Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjogren\u2019s Syndrome","volume":"42","author":"Lee","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3313","article-title":"Sjogren\u2019s syndrome: Studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/154411130201300103","article-title":"Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update","volume":"13","author":"Cha","year":"2002","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.4049\/jimmunol.179.4.2318","article-title":"Development of Sjogren\u2019s syndrome in nonobese diabetic-derived autoimmune-prone C57BL\/6.NOD-Aec1Aec2 mice is dependent on complement component-3","volume":"179","author":"Nguyen","year":"2007","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren\u2019s syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_22","first-page":"675","article-title":"Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice","volume":"16","author":"Kong","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sjogren\u2019s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J. Autoimmun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4049\/jimmunol.179.1.382","article-title":"IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjogren\u2019s Syndrome-like disease of the nonobese diabetic mouse","volume":"179","author":"Nguyen","year":"2007","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.molimm.2005.09.003","article-title":"Role of complement and B lymphocytes in Sjogren\u2019s syndrome-like autoimmune exocrinopathy of NOD.B10-H2(B) mice","volume":"43","author":"Nguyen","year":"2006","journal-title":"Mol. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar3207","article-title":"Pathogenic effect of interleukin-17A in induction of Sjogren syndrome-like disease using adenovirus-mediated gene transfer","volume":"12","author":"Nguyen","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of autoimmunity in IL-14\u03b1-transgenic mice","volume":"177","author":"Shen","year":"2006","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","article-title":"IL-14 alpha, the nexus for primary Sjogren\u2019s disease in mice and humans","volume":"130","author":"Shen","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.10258","article-title":"Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren\u2019s syndrome) on a healthy murine background","volume":"46","author":"Cha","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar4362","article-title":"Transcriptional landscapes of emerging autoimmunity: Transient aberrations in the targeted tissue\u2019s extracellular milieu precede immune responses in Sjogren\u2019s syndrome","volume":"15","author":"Delaleu","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: Emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clim.2016.06.007","article-title":"BAFF overexpression increases lymphocytic infiltration in Sjogren\u2019s target tissue, but only inefficiently promotes ectopic B-cell differentiation","volume":"169","author":"Ding","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sjogren\u2019s syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.4049\/jimmunol.1001520","article-title":"A Role for Lymphotoxin in Primary Sjogren\u2019s Disease","volume":"185","author":"Shen","year":"2010","journal-title":"J. Immunol."},{"doi-asserted-by":"crossref","unstructured":"Peck, A.B., Nguyen, C.Q., and Ambrus, J. (2021). Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjogren\u2019s Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Int. J. Mol. Sci., 22.","key":"ref_36","DOI":"10.3390\/ijms22041919"},{"doi-asserted-by":"crossref","unstructured":"Peck, A.B., Nguyen, C.Q., and Ambrus, J.L. (2021). Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjogren\u2019s Syndrome-Susceptible C57BL\/6.NOD-Aec1Aec2 Mice. Int. J. Mol. Sci., 22.","key":"ref_37","DOI":"10.3390\/ijms22137176"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2353\/ajpath.2007.070388","article-title":"Autoimmune dacryoadenitis of NOD\/Lt mice and its subsequent effects on tear protein composition","volume":"171","author":"Doyle","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni.3657","article-title":"Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10","volume":"18","author":"Hammad","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fonc.2018.00550","article-title":"The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies","volume":"8","author":"Arruga","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80157-0","article-title":"Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk","volume":"12","author":"Martin","year":"2000","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2005.04.009","article-title":"Marginal zone B cells in lymphocyte activation and regulation","volume":"17","author":"Foote","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: Virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12643","article-title":"Interleukin (IL)-22 receptoris over-expressed in primary Sjogren\u2019s syndrome and Sjogren-associated non-Hodgkin lymphomas and is regulated by IL-18","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.4049\/jimmunol.175.12.8173","article-title":"Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A","volume":"175","author":"Chen","year":"2005","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1071632","article-title":"Integrin-mediated long-term B cell retention in the splenic marginal zone","volume":"297","author":"Lu","year":"2002","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1167\/iovs.11-7652","article-title":"Gene expression profiling of early-phase Sjogren\u2019s syndrome in C57BL\/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes","volume":"52","author":"Peck","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri2606","article-title":"Rho family GTPases and their regulators in lymphocytes","volume":"9","author":"Tybulewicz","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.06.005","article-title":"Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration","volume":"43","author":"Namekata","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejcb.2014.06.003","article-title":"Dock-family exchange factors in cell migration and disease","volume":"93","author":"Gadea","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1083\/jcb.201612069","article-title":"Rho GTPase signaling complexes in cell migration and invasion","volume":"217","author":"Lawson","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2007-09-112169","article-title":"Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells","volume":"111","author":"Gotoh","year":"2008","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/clin.1996.0050","article-title":"Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis of NOD mice","volume":"79","author":"Robinson","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exer.2009.10.008","article-title":"Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren\u2019s syndrome exocrinopathy","volume":"90","author":"Xie","year":"2010","journal-title":"Exp. Eye Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren\u2019s syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.immuni.2008.12.016","article-title":"Lunatic and Manic Fringe Cooperatively Marginal Zone B Cell Precursor Competition for Delta-like 1 in Splenic Endothelial Niches","volume":"30","author":"Tan","year":"2009","journal-title":"Immunity"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.4049\/jimmunol.169.12.6686","article-title":"Cutting edge: Selection of B lymphocyte subsets is regulated by natural IgM","volume":"169","author":"Baker","year":"2002","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2016.04.008","article-title":"Central role for marginal zone B cells in an animal model of Sjogren\u2019s syndrome","volume":"168","author":"Shen","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/sji.12520","article-title":"Expression of Toll-Like Receptors in Peripheral Blood Mononuclear Cells of Patients with Primary Sjogren\u2019s Syndrome","volume":"85","author":"Karlsen","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12016-019-08740-1","article-title":"The Innate Part of the Adaptive Immune System","volume":"58","author":"Hillion","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.20030684","article-title":"Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone","volume":"198","author":"Karlsson","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ni1083","article-title":"Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone","volume":"5","author":"Cinamon","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ni0901-855","article-title":"Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses","volume":"2","author":"Girkontaite","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI118629","article-title":"Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren\u2019s syndrome","volume":"97","author":"Matsumoto","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren\u2019s syndrome: Contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.163.4.2226","article-title":"Preferential localization of CD8+ \u03b1E\u03b27+ T cells around acinar epithelial cells with apoptosis in patients with Sjogren\u2019s syndrome","volume":"163","author":"Fujihara","year":"1999","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10753-011-9356-y","article-title":"Destruction of Salivary and Lacrimal Glands by Th1-Polarized Reaction in a Model of Secondary Sjogren\u2019s Syndrome in Lupus-Prone Female NZB \u00d7 NZWF1 Mice","volume":"35","author":"Hayashi","year":"2012","journal-title":"Inflammation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41467-017-02482-4","article-title":"The opposing forces of shear flow and sphingosine-1-phosphate control marginal zone B cell shuttling","volume":"8","author":"Tedford","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.0105-2896.2004.0112.x","article-title":"Development and selection of marginal zone B cells","volume":"197","author":"Kearney","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/BOR.0b013e3283025ed4","article-title":"The role of innate immunity in autoimmune tissue injury","volume":"20","author":"Allam","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20160415","article-title":"The innate immune system in human systemic lupus erythematosus","volume":"131","author":"Weidenbusch","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/eji.1830270935","article-title":"Marginal Zone B Cells Exhibit Unique Activation, Proliferative and Immunoglobulin Secretory Responses","volume":"27","author":"Oliver","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","article-title":"Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity","volume":"48","author":"Colonna","year":"2018","journal-title":"Immunity"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.2830","article-title":"Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells","volume":"15","author":"Magri","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08916930903510872","article-title":"Type I interferons in systemic autoimmunity","volume":"43","author":"Sozzani","year":"2010","journal-title":"Autoimmunity"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ni.2239","article-title":"NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4","volume":"13","author":"Cui","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.smim.2009.10.006","article-title":"How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens","volume":"22","author":"Brigl","year":"2010","journal-title":"Semin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/db07-0589","article-title":"Marginal-zone B-Cells of Nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-Cells","volume":"57","author":"Marino","year":"2008","journal-title":"Diabetes"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2005.09.018","article-title":"Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response","volume":"23","author":"Rubtsov","year":"2005","journal-title":"Immunity"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar2560","article-title":"Identification of possible candidate genes regulating Sjogren\u2019s syndrome-associated autoimmunity: A potential role for TNFSF4 in autoimmune exocrinopathy","volume":"10","author":"Nguyen","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/88756","article-title":"Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling","volume":"2","author":"Tedford","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1126\/scisignal.aai9192","article-title":"Profiling the origin, dynamics, and function of traction force in B cell activation","volume":"11","author":"Wang","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1091\/mbc.E15-09-0670","article-title":"PAR3-aPKC regulates Tiam1 by modulating suppressive internal interactions","volume":"27","author":"Matsuzawa","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.imbio.2016.07.015","article-title":"Dock10 regulates CD23 expression and sustains B-cell lymphopoiesis in secondary lymphoid tissue","volume":"221","author":"Martinez","year":"2016","journal-title":"Immunobiology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.immuni.2004.07.012","article-title":"Differential requirements for DOCK2 and phosphoinositide-3-kinase \u03b3 during T and B lymphocyte homing","volume":"21","author":"Lacalle","year":"2004","journal-title":"Immunity"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fimmu.2018.00243","article-title":"The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production","volume":"9","author":"Ushijima","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.exer.2008.10.006","article-title":"Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren\u2019s syndrome (SJS)-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"88","author":"Nguyen","year":"2009","journal-title":"Exp. Eye Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2676","article-title":"Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren\u2019s syndrome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"11","author":"Nguyen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.immuni.2005.08.007","article-title":"Evidence of marginal-zone B cell-positive selection in spleen","volume":"23","author":"Wen","year":"2005","journal-title":"Immunity"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjanini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6106\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:21:01Z","timestamp":1760138461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,29]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23116106"],"URL":"https:\/\/doi.org\/10.3390\/ijms23116106","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2022,5,29]]}}}